Juan Peng MM, Quxi Zhao MM, Wei Pang MM, Yanjuan Li MM, Xudong Dong PhD
{"title":"Changes of coagulation function and platelet parameters in preeclampsia and their correlation with pregnancy outcomes","authors":"Juan Peng MM, Quxi Zhao MM, Wei Pang MM, Yanjuan Li MM, Xudong Dong PhD","doi":"10.1111/jch.14893","DOIUrl":null,"url":null,"abstract":"<p>Preeclampsia (PE) is a severe pregnancy complication characterized by significant alterations in coagulation function. This study aims to analyze the correlation between coagulation function, platelet parameters, and pregnancy outcomes in PE patients. Clinical data, along with blood and urine samples, were collected from 168 PE patients and 128 healthy pregnant women. General demographic and laboratory testing data were recorded, and maternal and fetal outcomes were followed up. Data were analyzed using Kaplan–Meier and logistic regression analyses. In mild PE patients, thrombin time (<i>p</i> = .000), platelet distribution width (PDW) (<i>p</i> = .000), and clot formation time (<i>p</i> = .000) were increased, while prothrombin time (<i>p</i> = .000) and fibrinogen (<i>p</i> = .045) were reduced. With increasing PE severity, prothrombin time (<i>p</i> = .000), platelet count (PLT) (<i>p</i> = .000), mean platelet volume (MPV) (<i>p</i> = .000), plateletcrit (<i>p</i> = .000), maximum amplitude (MA) (<i>p</i> = .000), and coagulation index (<i>p</i> = .001) decreased, whereas activated partial thromboplastin time (APTT) (<i>p</i> = .000), thrombin time (<i>p</i> = .002), D-dimer (<i>p</i> = .026), and PDW (<i>p</i> = .000) increased. Lower prothrombin time (<i>p</i> = .048), PLT (<i>p</i> = .004), and coagulation index (<i>p</i> = .026) or higher APTT (<i>p</i> = .032), thrombin time (<i>p</i> = .044), D-dimer (<i>p</i> = .023), and PDW (<i>p</i> = .016) were associated with a higher risk of poor pregnancy outcomes. Thrombin time was identified as an independent risk factor (<i>p</i> = .025, OR = 2.918, 95% CI: 1.145–7.436), whereas gestational age was an independent protective factor (<i>p</i> = .000, OR = 0.244, 95% CI: 0.151–0.395). This study demonstrates that specific coagulation and platelet parameters are significantly associated with PE severity and adverse pregnancy outcomes. These findings highlight the importance of monitoring coagulation function in PE patients to improve clinical management and outcomes.</p>","PeriodicalId":50237,"journal":{"name":"Journal of Clinical Hypertension","volume":null,"pages":null},"PeriodicalIF":2.7000,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11466355/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Hypertension","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jch.14893","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
Abstract
Preeclampsia (PE) is a severe pregnancy complication characterized by significant alterations in coagulation function. This study aims to analyze the correlation between coagulation function, platelet parameters, and pregnancy outcomes in PE patients. Clinical data, along with blood and urine samples, were collected from 168 PE patients and 128 healthy pregnant women. General demographic and laboratory testing data were recorded, and maternal and fetal outcomes were followed up. Data were analyzed using Kaplan–Meier and logistic regression analyses. In mild PE patients, thrombin time (p = .000), platelet distribution width (PDW) (p = .000), and clot formation time (p = .000) were increased, while prothrombin time (p = .000) and fibrinogen (p = .045) were reduced. With increasing PE severity, prothrombin time (p = .000), platelet count (PLT) (p = .000), mean platelet volume (MPV) (p = .000), plateletcrit (p = .000), maximum amplitude (MA) (p = .000), and coagulation index (p = .001) decreased, whereas activated partial thromboplastin time (APTT) (p = .000), thrombin time (p = .002), D-dimer (p = .026), and PDW (p = .000) increased. Lower prothrombin time (p = .048), PLT (p = .004), and coagulation index (p = .026) or higher APTT (p = .032), thrombin time (p = .044), D-dimer (p = .023), and PDW (p = .016) were associated with a higher risk of poor pregnancy outcomes. Thrombin time was identified as an independent risk factor (p = .025, OR = 2.918, 95% CI: 1.145–7.436), whereas gestational age was an independent protective factor (p = .000, OR = 0.244, 95% CI: 0.151–0.395). This study demonstrates that specific coagulation and platelet parameters are significantly associated with PE severity and adverse pregnancy outcomes. These findings highlight the importance of monitoring coagulation function in PE patients to improve clinical management and outcomes.
期刊介绍：
The Journal of Clinical Hypertension is a peer-reviewed, monthly publication that serves internists, cardiologists, nephrologists, endocrinologists, hypertension specialists, primary care practitioners, pharmacists and all professionals interested in hypertension by providing objective, up-to-date information and practical recommendations on the full range of clinical aspects of hypertension. Commentaries and columns by experts in the field provide further insights into our original research articles as well as on major articles published elsewhere. Major guidelines for the management of hypertension are also an important feature of the Journal. Through its partnership with the World Hypertension League, JCH will include a new focus on hypertension and public health, including major policy issues, that features research and reviews related to disease characteristics and management at the population level.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
